ResMed names Microsoft, Google execs to board
By HME News Staff
Updated 9:20 AM CST, Mon November 22, 2021
SAN DIEGO – ResMed has elected Desney Tan and John Hernandez, both digital health leaders at leading tech companies, to its board of directors. “We’re pleased to welcome Desney Tan and John Hernandez to ResMed’s board,” said Peter Farrell, ResMed’s founder and board chairman. “We are fortunate to leverage their expertise in digital health and health economics outcomes research as we continue to expand our leadership in digital health and improve the lives of millions of people around the world.” Tan is vice president and managing director for Health and Life Science R&D at Microsoft, where he’s worked in various research roles since 2004. He is the named inventor on more than 100 granted patents and is the author of numerous academic publications on topics relevant to ResMed’s long-term strategy, such as artificial intelligence, machine learning and human-computer interaction. Hernandez is clinical director and head of clinical research, health economics and outcomes research at Google. Over the past 20 years, he has led similar work at Verily, Abbott Laboratories and Boston Scientific Corporation. He lectures frequently on topics relevant to ResMed’s long-term strategy, such as digital health, real-world evidence strategies and value-based payment systems.
Comments